We are professional Raw Material Manufacturer, with more than 10 years' experience.
Please contact us for more information and detailed quotation
Email: sales12@sgonekbio.com
Phone/WhatsApp/Wechat: +86 13572550462


*The following content is generated by AI and is for reference only.
Monobenzone, chemically known as 4-tert-butylphenol monobenzyl ether, is a potent depigmenting agent widely utilized in dermatological practice for the permanent treatment of extensive vitiligo. Its molecular formula is C15H16O2, and it is identified by the CAS Registry Number 7483-97-0. This compound functions through a unique mechanism of action distinct from other skin-lightening agents. Unlike hydroquinone, which temporarily inhibits melanin production, Monobenzone acts as a cytotoxic agent that selectively destroys residual melanocytes in the epidermis. Once applied to the skin, it is converted into reactive metabolites that trigger an autoimmune-like response, leading to the irreversible loss of pigment cells.
The primary clinical indication for Monobenzone extract is in patients with generalized or widespread vitiligo where repigmentation therapies have failed or are impractical due to the sheer extent of depigmented areas. By achieving complete and permanent depigmentation, the product allows individuals to achieve a uniform skin tone, eliminating the psychological distress associated with patchy coloration. It is typically formulated as a 20% cream for topical application, often requiring careful medical supervision during the initiation phase to manage potential irritation or allergic contact dermatitis. Because the depigmentation induced by Monobenzone is permanent, patient selection is critical; candidates must fully understand that any remaining pigmented skin will eventually fade, resulting in total achromia. Consequently, strict sun protection is mandatory post-treatment to prevent severe sunburn on the now unprotected skin. While effective, its use is restricted to specialized settings due to the irreversible nature of the outcome and the risk of unpredictable spread of depigmentation. Overall, Monobenzone remains a cornerstone therapy for specific cases of vitiligo, offering a definitive solution for cosmetic uniformity when other options are exhausted.